Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures.

MLA

Chiu, Winston, et al. “Development and Optimization of a High-Throughput Screening Assay for in Vitro Anti-SARS-CoV-2 Activity: Evaluation of 5676 Phase 1 Passed Structures.” Journal of Medical Virology, vol. 94, no. 7, July 2022, pp. 3101–11. EBSCOhost, https://doi.org/10.1002/jmv.27683.

APA

Chiu, W., Verschueren, L., Van den Eynde, C., Buyck, C., De Meyer, S., Jochmans, D., Bojkova, D., Ciesek, S., Cinatl, J., De Jonghe, S., Leyssen, P., Neyts, J., Van Loock, M., & Van Damme, E. (2022). Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures. Journal of Medical Virology, 94(7), 3101–3111. https://doi.org/10.1002/jmv.27683

Chicago

Chiu, Winston, Lore Verschueren, Christel Van den Eynde, Christophe Buyck, Sandra De Meyer, Dirk Jochmans, Denisa Bojkova, et al. 2022. “Development and Optimization of a High-Throughput Screening Assay for in Vitro Anti-SARS-CoV-2 Activity: Evaluation of 5676 Phase 1 Passed Structures.” Journal of Medical Virology 94 (7): 3101–11. doi:10.1002/jmv.27683.